Suppr超能文献

用于生产治疗性外泌体的平台技术和人类细胞系。

Platform technologies and human cell lines for the production of therapeutic exosomes.

作者信息

Kim Jiyoon, Song Yonghee, Park Cheol Hyoung, Choi Chulhee

机构信息

ILIAS Biologics Inc., Daejeon 34014, South Korea.

Authors contributed equally.

出版信息

Extracell Vesicles Circ Nucl Acids. 2021 Mar 30;2(1):3-17. doi: 10.20517/evcna.2020.01. eCollection 2021.

Abstract

Exosomes are extracellular vesicles secreted by most cell types and represent various biological properties depending on their producing cells. They are also known to be important mediators of intercellular communication. Recent data suggest that exosomes can mediate the therapeutic effects of their parental cells; hence, they have been in the spotlight as novel therapeutics. To develop and manufacture effective therapeutic exosomes, customized strategies are needed to use appropriate technologies for exosome engineering and to select suitable production cell lines. In this review, we provide an overview of currently available exosome engineering platform technologies for loading active pharmaceutical ingredient cargo and the types of human cells/cell lines that are being used as exosome-producing cells, particularly focusing on their characteristics, advantages, and disadvantages.

摘要

外泌体是大多数细胞类型分泌的细胞外囊泡,根据其产生细胞的不同具有多种生物学特性。它们也是细胞间通讯的重要介质。最近的数据表明,外泌体可以介导其亲代细胞的治疗作用;因此,它们作为新型治疗剂备受关注。为了开发和制造有效的治疗性外泌体,需要定制策略,以使用适当的技术进行外泌体工程改造,并选择合适的生产细胞系。在这篇综述中,我们概述了目前可用于装载活性药物成分的外泌体工程平台技术,以及用作外泌体产生细胞的人类细胞/细胞系类型,特别关注它们的特性、优点和缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ec/11648496/2b4662af0d1c/evcna-2-1-3.fig.1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验